Skip to content

Effects of Table Tennis for People With Parkinson's Disease

Motor and Cognitive Effects of Table Tennis on Parkinson's Disease: Pilot Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06444685
Enrollment
20
Registered
2024-06-05
Start date
2023-10-01
Completion date
2026-06-30
Last updated
2024-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

Quasi-experimental, controlled, non-randomised two-arm pilot, with an experimental group (table tennis exercise) and an active control group (cognitive training based on board games).

Detailed description

Quasi-experimental, controlled, non-randomised two-arm pilot, with an experimental group (table tennis exercise) and an active control group (cognitive training based on board games). Interventions in both groups will take place twice a week for 6 weeks (12 sessions in total). The main variables to be assessed will be motor and cognitive. As secondary variables, clinical and daily life aspects will be assessed. As results, it is expected that the experimental group will obtain improvements in motor variables compared to the control group after receiving the interventions. However, improvements in cognitive variables and secondary variables are expected to be similar in both groups.

Interventions

OTHERExercise and cognitive training interventino

Exercise and cognitive training based on Table tennis and Tabletop games.

Sponsors

Club Tennis Taula Borges Blanques
CollaboratorUNKNOWN
Asociació de Parkinson de les Terres de Lleida
CollaboratorUNKNOWN
Universitat de Lleida
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Parkinson's Disease based on the UK PD Society Brain Bank Criteria * Stage I to III on the Hoehn and Yahr scale * Ability to walk for 10 minutes unassisted

Exclusion criteria

* Score of under 23 on the Mini-Mental State Examination * Severe Visual or Auditory deficits * Cardiovascular conditions that impede physical activity * Brain surgery

Design outcomes

Primary

MeasureTime frameDescription
Trail-Making TestAssessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).Assessment of Trail-Making Test parts A and B
Amplitude of Center of Pressure under simple conditionsAssessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).Assessment of amplitude of Center of Pressure (in mm) during balance testing using OPAL Sensors (APDM, Oregon, USA).
Amplitude of Center of Pressure under Dual Task conditions (Motor)Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).Assessment of amplitude of Center of Pressure (in mm) during balance testing under concurrent cognitive tasks (Motor, by holding a glass of water on a tray) using OPAL Sensors (APDM, Oregon, USA).
Amplitude of Center of Pressure under Dual Task conditions (Arithmetic)Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).Assessment of amplitude of Center of Pressure (in mm) during balance testing under concurrent cognitive tasks (Arithmetic, by concurrently substracting 7 from a random number) using OPAL Sensors (APDM, Oregon, USA).
Amplitude of Center of Pressure under Dual Task conditions (Verbal)Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).Assessment of amplitude of Center of Pressure (in mm) during balance testing under concurrent cognitive tasks (Verbal, by naming words starting by a random letter) using OPAL Sensors (APDM, Oregon, USA).

Secondary

MeasureTime frameDescription
United Parkinson's Disease Rating Scale - Part IIIAssessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).Assessment of Motor symptoms of Parkinson's Disease with a predetermined assessment
Montreal Cognitive AssessmentAssessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).Assessment of cognitive status to detect Mild Cognitive Impairment with a preset questionnaire.
Parkinson's Disease Questionnaire - 8Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).Assessment of Quality of Life for people with Parkinson's Disease through a self-administered questionnaire
Timed Up and Go testAssessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).Assessment of gait mobility and fall risk by getting up from a chair, walking 3 meters, turning back and sitting again.
Falls Efficacy Scale InternationalAssessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).Assessment of perceived fall risk with a predetermined questionnaire.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026